Tulosta

Ulkuksen ja mahasyövän riskitekijät

Lisätietoa aiheesta
10.4.2019
tarkastanut: Jorma Komulainen; alkuperäinen kirjoittaja: Anna-Liisa Karvonen
Taulukko 1. Ulkustaudin riskitekijöitä.
Riskitekijä Viitteet
helikobakteeri-infektio «Voutilainen M, Mäntynen T, Färkkilä M ym. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease. Scand J Gastroenterol 20»3
tulehduskipulääkkeiden käyttö «Voutilainen M, Mäntynen T, Färkkilä M ym. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease. Scand J Gastroenterol 20»3
ikä yli 50 vuotta «Lassen A, Hallas J, Schaffalitzky de Muckadell OB. Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study. Am J Gastroenterol 2006;101:945-53 »4, «Garrow D, Delegge MH. Risk factors for gastrointestinal ulcer disease in the US population. Dig Dis Sci 2010;55:66-72 »5, «Ahsberg K, Ye W, Lu Y ym. Hospitalisation of and mortality from bleeding peptic ulcer in Sweden: a nationwide time-trend analysis. Aliment Pharmacol Ther 2011;33:578-84 »19
tupakointi «Garrow D, Delegge MH. Risk factors for gastrointestinal ulcer disease in the US population. Dig Dis Sci 2010;55:66-72 »5
krooninen sydän-, munuais- tai keuhkosairaus «Garrow D, Delegge MH. Risk factors for gastrointestinal ulcer disease in the US population. Dig Dis Sci 2010;55:66-72 »5
Taulukko 2. Mahasyövän riskitekijöitä «Uemura N, Okamoto S, Yamamoto S ym. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9 »1, «Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-53 »2, «Karttunen T, Kivilaakso E. Mahalaukun kasvaimet. Kirjassa: Gastroenterologia ja hepatologia. Höckerstedt K, Färkkilä M, Kivilaakso E, Pikkarainen P (toim). Kustannus Oy Duodecim 2007:332-3»6, «Sipponen P, Kekki M, Haapakoski J ym. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985;35:173-7 »7.
Viitteet
krooninen atrofinen gastriitti «Karttunen T, Kivilaakso E. Mahalaukun kasvaimet. Kirjassa: Gastroenterologia ja hepatologia. Höckerstedt K, Färkkilä M, Kivilaakso E, Pikkarainen P (toim). Kustannus Oy Duodecim 2007:332-3»6
helikobakteeri-infektio «Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-53 »2
ventrikkeliresektion jälkeinen tynkämaha
polyypit
(myös hyperplastiset yhdessä atrofian kanssa)
suvussa esiintyvä mahasyöpä
tupakointi

Kirjallisuutta

  1. Uemura N, Okamoto S, Yamamoto S ym. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9 «PMID: 11556297»PubMed
  2. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-53 «PMID: 11511555»PubMed
  3. Voutilainen M, Mäntynen T, Färkkilä M ym. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease. Scand J Gastroenterol 2001;36:817-21 «PMID: 11495076»PubMed
  4. Lassen A, Hallas J, Schaffalitzky de Muckadell OB. Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study. Am J Gastroenterol 2006;101:945-53 «PMID: 16573778»PubMed
  5. Garrow D, Delegge MH. Risk factors for gastrointestinal ulcer disease in the US population. Dig Dis Sci 2010;55:66-72 «PMID: 19160043»PubMed
  6. Karttunen T, Kivilaakso E. Mahalaukun kasvaimet. Kirjassa: Gastroenterologia ja hepatologia. Höckerstedt K, Färkkilä M, Kivilaakso E, Pikkarainen P (toim). Kustannus Oy Duodecim 2007:332-3
  7. Sipponen P, Kekki M, Haapakoski J ym. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985;35:173-7 «PMID: 3871738»PubMed
  8. Papatheodoridis GV, Sougioultzis S, Archimandritis AJ. Effects of Helicobacter pylori and nonsteroidal anti-inflammatory drugs on peptic ulcer disease: a systematic review. Clin Gastroenterol Hepatol 2006;4:130-42 «PMID: 16469671»PubMed
  9. Tielemans MM, Eikendal T, Jansen JB ym. Identification of NSAID users at risk for gastrointestinal complications: a systematic review of current guidelines and consensus agreements. Drug Saf 2010;33:443-53 «PMID: 20486727»PubMed
  10. Heikkinen M, Färkkilä M. Long-term outcome of functional dyspepsia: effect of Helicobacter pylori infection. A 6- to 7-year follow-up study. Scand J Gastroenterol 2002;37:905-10 «PMID: 12229964»PubMed
  11. Voutilainen M, Mäntynen T, Kunnamo I ym. Impact of clinical symptoms and referral volume on endoscopy for detecting peptic ulcer and gastric neoplasms. Scand J Gastroenterol 2003;38:109-13 «PMID: 12613446»PubMed
  12. Piper JM, Ray WA, Daugherty JR ym. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med 1991;114:735-40 «PMID: 2012355»PubMed
  13. Conn HO, Poynard T. Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy. J Intern Med 1994;236:619-32 «PMID: 7989897»PubMed
  14. Nielsen GL, Sørensen HT, Mellemkjoer L ym. Risk of hospitalization resulting from upper gastrointestinal bleeding among patients taking corticosteroids: a register-based cohort study. Am J Med 2001;111:541-5 «PMID: 11705430»PubMed
  15. Hernández-Díaz S, Rodríguez LA. Steroids and risk of upper gastrointestinal complications. Am J Epidemiol 2001;153:1089-93 «PMID: 11390328»PubMed
  16. Martínek J, Hlavova K, Zavada F ym. "A surviving myth"--corticosteroids are still considered ulcerogenic by a majority of physicians. Scand J Gastroenterol 2010;45:1156-61 «PMID: 20569095»PubMed
  17. Dall M, Schaffalitzky de Muckadell OB, Lassen AT ym. There is an association between selective serotonin reuptake inhibitor use and uncomplicated peptic ulcers: a population-based case-control study. Aliment Pharmacol Ther 2010;32:1383-91 «PMID: 21050241»PubMed
  18. Loke YK, Trivedi AN, Singh S. Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2008;27:31-40 «PMID: 17919277»PubMed
  19. Ahsberg K, Ye W, Lu Y ym. Hospitalisation of and mortality from bleeding peptic ulcer in Sweden: a nationwide time-trend analysis. Aliment Pharmacol Ther 2011;33:578-84 «PMID: 21210831»PubMed
  20. Kosunen TU, Aromaa A, Knekt P ym. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect 1997;119:29-34 «PMID: 9287940»PubMed
  21. Harvey RF, Spence RW, Lane JA ym. Relationship between the birth cohort pattern of Helicobacter pylori infection and the epidemiology of duodenal ulcer. QJM 2002;95:519-25 «PMID: 12145391»PubMed
Käypä hoito -suositukset ovat riippumattomia, tutkimusnäyttöön perustuvia kansallisia hoitosuosituksia. Lue lisää
KÄYPÄ HOITO -SUOSITUS Ylävatsavaivat ja refluksioireet
LINKKIEN TYYPIT JA VÄRIKOODIT
Kirjallisuusviite
Kuva
Linkki toiselle sivustolle
Lisätietoa
Näytönastekatsaus
PDF-tiedosto
PubMed-abstrakti
Taulukko